CD206/MRC1 Antibody

About the Target

CD206/MRC1 is a target of interest in many antibody-based workflows. CD206, also known as the mannose receptor or MRC1, is a type I transmembrane C-type lectin receptor predominantly expressed on macrophages, immature dendritic cells, and certain endothelial cells, playing a crucial role in immune surveillance and homeostasis. CD206 comprises an N-terminal cysteine-rich domain, a fibronectin type II domain, and eight C-type lectin carbohydrate recognition domains (CRDs) that mediate high-affinity binding to glycans containing terminal mannose, fucose, and N-acetylglucosamine residues. Depending on the literature source, CD206/MRC1 may also be discussed as CD206/MRC1 and Macrophage mannose receptor 1.

Reported cellular context includes cell membrane, endosome, and membrane, which can matter when signal is compared across treatments or changing cell states. Following CD206/MRC1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

CD206/MRC1 is commonly interpreted in the context of immunology, inflammation, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, endosome, and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell membrane, endosome, and membrane across matched conditions
• context differences tied to immune-cell state, activation, or lineage composition
• responses associated with cytokine exposure, inflammatory tone, or tissue stress
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CD206/MRC1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CD206/MRC1 reflect biology rather than handling. When interpreting CD206/MRC1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep CD206/MRC1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.